ACC重磅公布5场LBCT

5月15日ACCJACCLBCTⅠ

9–10a.m.ET

1

PARADISE-MI：比较ARNI与ACEI在减少心肌梗死后心力衰竭事件中的优势的前瞻性试验

PARADISE-MI:ProspectiveArniVersusAceInhibitorTrialToDetermineSuperiorityInReducingHeartFailureEventsAfterMyocardialInfarction

2

ADAPTABLE研究：以患者为中心评估不同剂量阿司匹林的疗效和长期有效性的试验

ADAPTABLEStudy:AspirinDosing:APatient-centricTrialAssessingBenefitsAndLong-termEffectivenessTrial

3

LAAOSIII：左心耳封堵研究Ⅲ

LAAOSIII:TheLeftAtrialAppendageOcclusionStudyIII

4

Atlantis随机试验：经主动脉瓣膜植入术治疗主动脉瓣狭窄后的口服抗Xa因子抑制剂抗凝治疗

RandomizedAtlantisTrial:OralAnti-xaAnticoagulationAfterTrans-aorticValveImplantationForAorticStenosis

FCRⅠ

12:15–1:30p.m.ET

1

EXPLORER-HCM随机临床试验结果：Mavacamten对症状性阻塞性肥厚型心肌病患者健康状况的益处

ResultsfromtheEXPLORER-HCMRandomizedClinicalTrial:HealthStatusBenefitsofMavacamtenInPatientswithSymptomaticObstructiveHypertrophicCardiomyopathy

2

NCDRLAAO注册研究报告：Watchman经导管左心耳封堵预防房颤患者术后卒中的一年临床随访结果

AReportFromtheNCDRLAAORegistry:One-yearClinicalOut

转载请注明：http://www.galanzweibolu.com/xjbzlzj/7335.html